Last reviewed · How we verify

NCT05006976: NSAC

A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study

Active, enrolled NA Last updated 13 April 2026
What this trial tests

NA trial testing NSAC health only in Musculoskeletal Disorder in 1,180 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
6 September 2021
Primary endpoint
12 April 2028
12 January 2033

Quick facts

Lead sponsorNordlandssykehuset HF
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment1,180
Start date6 September 2021
Primary completion12 April 2028
Estimated completion12 January 2033
Sites5 locations across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Nordlandssykehuset HF

Who can join

23 and older, any sex, with Musculoskeletal Disorder or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Norwegian Sickness Absence Clinic (NSAC) Nudge Study is a naturalistic randomized controlled multicentre trial which aim is to measure the efficacy of nudging clinicians' attention towards patients' motivation for work, barriers for return to work and work environment challenges, on functional recovery as primary outcome, and health outcomes as secondary outcome. Patients will be recruited in five different NSACs across northern Norway. In total 1100 patients will be randomized to two equal probability treatment arms: 1) NSAC with the nudge, and 2) NSAC without the nudge. The nudge is tailored to the individual patient's needs using survey, and the clinicians are presented with a summary of this patient survey prior to consultations highlighting health problems and challenges as reported by the patient in the survey.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Naturalistic trial of nudging patients and clinicians in the Norwegian sickness absence clinics: a study protocol for the NSAC Nudge Study.
    Aars NA, Bardal I, Brinchmann B, Mykletun A. · · 2025 · cited 2× · PMID 40032398 · DOI 10.1136/bmjopen-2024-089758
  2. Expanding the Focus on Work Factors in an Outpatient Setting: Does a Nudge of Patients and Clinicians have an Effect on Return-to-Work and Benefits? Findings from the NSAC Nudge Multicentre Randomised Controlled Trial.
    Bardal I, Aars NAP, Trichet LO, Brandseth OL, et al · · 2025 · cited 1× · PMID 41385138 · DOI 10.1007/s10926-025-10343-x
  3. Barriers for return to work as an iatrogenic effect of sickness absence: a proposed conceptual framework and questionnaire based on a cross-sectional study.
    Myhrer M, Brinchmann B, Trichet L, Aars NA, et al · · 2026 · PMID 41680726 · DOI 10.1186/s12889-026-26584-1

Verify or expand the search:

Other Nordlandssykehuset HF trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006976.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing